Lower riskDrug recall · FDA · Published January 10, 2024
BE Pharmaceuticals Fosaprepitant Injection Recall: Sterility Risk After Reconstitution
BE Pharmaceuticals recalls Fosaprepitant 150mg vials due to potential sterility issues after reconstitution. This could lead to infections if used improperly. Check your vial's lot number and contact the company for details.
“BE Pharmaceuticals Fosaprepitant Injection Recall: Sterility Risk After Reconstitution.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/32887-be-pharmaceuticals-fosaprepitant-injection-recall-sterility-risk-after-reconstitution. Based on FDA recall #D-0262-2024 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0262-2024%22&limit=1).
BE Pharmaceuticals AG recalled Fosaprepitant for Injection 150 mg per vial nationwide on Jan. 10, 2024, due to a lack of sterility assurance from an aseptic process simulation failure, the FDA said.
How to tell if you have it
Brand: BE Pharmaceuticals
Product: Fosaprepitant for Injection 150 mg per vial, Sterile lyophilized powder for Intravenous use only after reconstitution
NDC: 71839-104-01
Lot code: 13D012AA
Expiration date: 08/31/2025
Quantity: 22,176 vials
The hazard
The recall addresses a lack of sterility assurance resulting from an aseptic process simulation failure. The FDA classified the recall as Class II.
Context
GovInfoNow's records show BE PHARMACEUTICALS AG has one other recall on record since Sept. 5, 2023: a Sept. 5, 2023 recall of Pantoprazole Sodium 40mg Vials due to sterility risk from vial cracks. Other recent recalls of similar products include a June 24, 2026 Reliance Pemetrexed Injection Recall for sterility risk in IV doses and a July 28, 2026 Regeneron Libtayo injection recall for lack of sterility assurance risk.
How to tell if you have this one
Check for the vial label with 'Fosaprepitant for Injection 150 mg per vial, Sterile lyophilized powder for Intravenous use only after reconstitution'. The lot number is 13D012AA and expiration date is 08/31/2025.
Brand
BE Pharmaceuticals
Category
Drug
Based on the official FDA remedy
What to do — step by step
Check Vial Label
Look for the product name and lot number on the vial label to confirm if it's part of the recall.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “Nationwide in the USA” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 17 months after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
4FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-0262-2024 (January 10, 2024) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0262-2024 to see it in context.
Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.